SenesTech Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SenesTech in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SenesTech stock.
View analyst ratings for SenesTech or view top-rated stocks.

Wall Street analysts have given SenesTech a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but SenesTech wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

SenesTech saw a drop in short interest in the month of May. As of May 28th, there was short interest totaling 250,000 shares, a drop of 22.4% from the May 13th total of 322,100 shares. Based on an average daily trading volume, of 1,750,000 shares, the days-to-cover ratio is currently 0.1 days. Currently, 2.5% of the company's stock are sold short.
View SenesTech's Short Interest.

SenesTech is scheduled to release its next quarterly earnings announcement on Wednesday, August 11th 2021.
View our earnings forecast for SenesTech.

SenesTech, Inc. (NASDAQ:SNES) released its earnings results on Thursday, May, 13th. The company reported ($0.22) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.16) by $0.06. SenesTech had a negative trailing twelve-month return on equity of 107.54% and a negative net margin of 2,241.14%.
View SenesTech's earnings history.

SenesTech's stock was trading at $2.48 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SNES shares have decreased by 35.9% and is now trading at $1.59.
View which stocks have been most impacted by COVID-19.

SenesTech shares reverse split on Wednesday, February 5th 2020. The 1-20 reverse split was announced on Tuesday, February 4th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 4th 2020. An investor that had 100 shares of SenesTech stock prior to the reverse split would have 5 shares after the split.

1 equities research analysts have issued 1 year price objectives for SenesTech's shares. Their forecasts range from $4.00 to $4.00. On average, they expect SenesTech's share price to reach $4.00 in the next year. This suggests a possible upside of 151.6% from the stock's current price.
View analysts' price targets for SenesTech or view top-rated stocks among Wall Street analysts.

Some companies that are related to SenesTech include Bion Environmental Technologies (BNET), Eden Research (EDEN), Save Foods (SVFD), Kiwa Bio-Tech Products Group (KWBT), Cavitation Technologies (CVAT), China Agri-Business (CHBU), Igene Biotechnology (IGNE) and Nufarm (NUF).
View all of SNES's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other SenesTech investors own include TransEnterix (TRXC), Carrizo Oil & Gas (CRZO), Auris Medical (EARS), Marathon Oil (MRO), Adamis Pharmaceuticals (ADMP), McDermott International (MDR), ZIOPHARM Oncology (ZIOP), Catabasis Pharmaceuticals (CATB), Citius Pharmaceuticals (CTXR) and DURECT (DRRX).

(SNES) raised $15 million in an initial public offering on Thursday, December 8th 2016. The company issued 1,900,000 shares at $8.00 per share. Roth Capital Partners acted as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.

SenesTech trades on the NASDAQ under the ticker symbol "SNES."

SenesTech's stock is owned by a number of retail and institutional investors. Top institutional investors include Virtu Financial LLC (0.89%), Sheaff Brock Investment Advisors LLC (0.87%), Bank of New York Mellon Corp (0.66%) and Dimensional Fund Advisors LP (0.56%). Company insiders that own SenesTech stock include Cheryl Ann Dyer, Kenneth S Siegel and Loretta Powers Mayer.
View institutional ownership trends for SenesTech.

SNES stock was bought by a variety of institutional investors in the last quarter, including Virtu Financial LLC, Sheaff Brock Investment Advisors LLC, Bank of New York Mellon Corp, and Dimensional Fund Advisors LP.
View insider buying and selling activity for SenesTech or or view top insider-buying stocks.

Shares of SNES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SNES stock can currently be purchased for approximately $1.59.

SenesTech has a market capitalization of $19.37 million and generates $280,000.00 in revenue each year. The company earns $-7,940,000.00 in net income (profit) each year or ($2.78) on an earnings per share basis.

SenesTech employs 29 workers across the globe.

The official website for SenesTech is www.senestech.com.

SenesTech is headquartered at 23460 NORTH 19TH AVENUE SUITE 110, PHOENIX AZ, 85027.

SenesTech's mailing address is 23460 NORTH 19TH AVENUE SUITE 110, PHOENIX AZ, 85027. The company can be reached via phone at (928) 779-4143 or via email at [email protected]